Rapid development of renal failure secondary to aa-type amyloidosis in a patient with polymyalgia rheumatica

Journal of Renal Care

Volumn 36, Issue 4, 2010, Pages 199-202

  Javaid, Muhammad Masoom ^a   Kamalanathan, Manivarma ^a   Kon, Sui Phin ^a  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

AA amyloidosis; Polymyalgia rheumatica; Renal failure

Indexed keywords

AGED; AMYLOIDOSIS; ARTICLE; CASE REPORT; FEMALE; HUMAN; KIDNEY FAILURE; RHEUMATIC POLYMYALGIA;

AGED; AMYLOIDOSIS; FEMALE; HUMANS; POLYMYALGIA RHEUMATICA; RENAL INSUFFICIENCY;

EID: 77958530610     PISSN: 17556678     EISSN: 17556686     Source Type: Journal    
DOI: 10.1111/j.1755-6686.2010.00200.x     Document Type: Article

References (11)

1. Altiparmak M.R., Tabak F., Pamuk O.N. et al (2001). Giant cell arteritis and secondary amyloidosis: the natural history. Scandinavian Journal of Rheumatology 30(2), 114-116.
2. Dember L.M. (2006). Amyloidosis-associated Kidney disease. Journal of the American Society of Nephrology 17, 3458-3471.
3. Dember L.M., Hawkins P.N., Hazenberg B.P. et al (2007). Eprodisate for the treatment of renal disease in AA amyloidosis. The New England Journal of Medicine 356(23), 2349-2360.
4. Escribá A., Morales E., Albizúa E. et al (2000). Secondary (AA-type) amyloidosis in patients with polymyalgia rheumatica. American Journal of Kidney Diseases 35(1), 137-140.
5. Gottenberg J.E., Merle-Vincent F., Bentaberry F. et al (2003). Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a follow up report of tolerability and efficacy. Arthritis and Rheumatism 48(7), 2019-2024.
6. Joss N., McLaughlin K., Simpson K. et al (2000). Presentation, surviva and prognostic markers in AA amyloidosis. The Quarterly Journal of Medicine 93(8), 535-542.
7. Lachmann H.J., Goodman H.J., Gilbertson J.A. et al (2007). Natura history and outcome in systemic AA amyloidosis. The New England Journal of Medicine 356, 2361-2371.
8. Monteagudo M., Vidal G., Andreu J. et al (1997). Giant cell (temporal) arteritis and secondary renal amyloidosis: report of 2 cases. The Journal of Rheumatology 24(3), 605-607.
9. Moraga S.J.J., Blanco J. et al (2001). Giant cell arteritis and rena amyloidosis: report of a case. Clinical Nephrology 56(5), 402-406.
10. Salvarani C, Cantini F. & Hunder G.G. (2008). Polymyalgia rheumatica and giant-cell arteritis. Lancet 372(9634), 234-245.
11. Thornton B.D., Hoffman H.M., Bhat A. et al (2007). Successful treatment of renal amyloidosis due to familial cold autoinflammatory syndrome using an interleukin 1 receptor antagonist. American Journal of Kidney Diseases 49(3), 477-481.